A Food and Drug Administration advisory committee is moving forward to discuss the use of booster dosages of the Moderna and Johnson & Johnson COVID-19 vaccines.

The committee is holding meetings on Oct. 14 and 15 to discuss an amendment to the emergency use authorization of the Moderna vaccine for the administration of a booster dose for those age 18 and older.

The same discussion will include amending the emergency use authorization for the Johnson & Johnson vaccine or the administration of a booster dose for those age 18 and older.

As part of the process, there will be an open public hearing over the course of 2 days.